Veterinary Medicines

RESPIBOV

Not authorised
  • Bovine herpesvirus 1, strain Colorado, Inactivated
  • Bovine viral diarrhoea virus, strain Singer, Inactivated
  • Bovine parainfluenza virus 3, strain SF-4, Inactivated
  • Mannheimia haemolytica, strain Salamanca, Inactivated
  • Pasteurella multocida, serotype D, strain Dario, Inactivated
Download as PDF

Product identification

Medicine name:
RESPIBOV
Active substance:
  • Bovine herpesvirus 1, strain Colorado, Inactivated
  • Bovine viral diarrhoea virus, strain Singer, Inactivated
  • Bovine parainfluenza virus 3, strain SF-4, Inactivated
  • Mannheimia haemolytica, strain Salamanca, Inactivated
  • Pasteurella multocida, serotype D, strain Dario, Inactivated
Target species:
  • Cattle
Route of administration:
  • Intramuscular use
  • Subcutaneous use

Product details

Active substance and strength:
  • Bovine herpesvirus 1, strain Colorado, Inactivated
    8.00
    serum neutralising unit(s)
    /
    1.00
    Dose
  • Bovine viral diarrhoea virus, strain Singer, Inactivated
    32.00
    serum neutralising unit(s)
    /
    1.00
    Dose
  • Bovine parainfluenza virus 3, strain SF-4, Inactivated
    64.00
    serum neutralising unit(s)
    /
    1.00
    Dose
  • Mannheimia haemolytica, strain Salamanca, Inactivated
    80.00
    enzyme-linked immunosorbent assay unit
    /
    1.00
    Dose
  • Pasteurella multocida, serotype D, strain Dario, Inactivated
    80.00
    enzyme-linked immunosorbent assay unit
    /
    1.00
    Dose
Pharmaceutical form:
  • Suspension for injection
Withdrawal period by route of administration:
  • Intramuscular use
    • Cattle
      • Meat and offal
        0
        day
  • Subcutaneous use
    • Cattle
      • Meat and offal
        0
        day
Anatomical therapeutic chemical veterinary (ATCvet) codes:
  • QI02AL
Legal status of supply:
  • Veterinary medicinal product subject to veterinary prescription
Authorisation status:
  • Surrendered
Authorised in:
  • Spain
Package description:

Additional information

Entitlement type:
  • Marketing Authorisation
Legal basis of product authorisation:
  • Full application - Known active substance (Article 12(3) of Directive No 2001/82/EC)
Marketing authorisation holder:
  • Laboratorios Syva S.A.
Marketing authorisation date:
Manufacturing sites for batch release:
  • Laboratorios Syva S.A.
Responsible authority:
  • Spanish Agency For Medicines And Health Products
Authorisation number:
  • 2862 ESP
Date of authorisation status change:

Documents

Summary of Product Characteristics

This document does not exist in this language (English). You can find it in another language below.
Spanish (PDF)
Published on: 9/11/2022
Download

Package Leaflet

This document does not exist in this language (English). You can find it in another language below.
Spanish (PDF)
Published on: 9/11/2022
Download

Labelling

This document does not exist in this language (English). You can find it in another language below.
Spanish (PDF)
Published on: 9/11/2022
Download
How useful was this page?:
No votes yet
"Please do not include any personal data, such as your name or contact details. If you do, you consent to the processing of that data in accordance with EMA’s Privacy Statement concerning requests for information or access to documents. If you would like a reply from EMA, please Send a question to EMA instead."